Immuneering Corp Cl A (IMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 15,274 | 14,914 | 15,326 | 16,302 | 13,926 |
| Operating Income | -15,274 | -14,914 | -15,326 | -16,302 | -13,926 |
| Other Income | 676 | 834 | 1,018 | 1,219 | 1,331 |
| Pre-tax Income | -14,597 | -14,080 | -14,308 | -15,084 | -12,595 |
| Net Income Continuous | -14,597 | -14,080 | -14,308 | -15,084 | -12,595 |
| Net Income | $-14,597 | $-14,080 | $-14,308 | $-15,084 | $-12,595 |
| EPS Basic Total Ops | -0.49 | -0.47 | -0.49 | -0.51 | -0.43 |
| EPS Basic Continuous Ops | -0.49 | -0.47 | -0.49 | -0.51 | -0.43 |
| EPS Diluted Total Ops | -0.49 | -0.47 | -0.49 | -0.51 | -0.43 |
| EPS Diluted Continuous Ops | -0.49 | -0.47 | -0.49 | -0.51 | -0.43 |
| EPS Diluted Before Non-Recurring Items | -0.49 | -0.47 | -0.49 | N/A | N/A |
| EBITDA(a) | $-15,132 | $-14,746 | $-15,300 | $-16,520 | $-14,043 |